OncoImmunology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.2 | Q1 | 82.3% | 2.438 | Q1 | 96.7% |
| 2024 | 6.3 | Q1 | 84.7% | 2.542 | Q1 | 97.0% |
| 2023 | 6.5 | Q1 | 83.7% | 2.345 | Q1 | 96.6% |
| 2022 | 7.2 | Q1 | 82.0% | 2.003 | Q1 | 95.7% |
| 2021 | 7.7 | Q1 | 82.8% | 2.096 | Q1 | 96.2% |
| 2020 | — | — | 3.049 | Q1 | 97.9% | |
| 2019 | — | — | 2.461 | Q1 | 96.9% | |
| 2018 | — | — | 2.253 | Q1 | 96.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2162-4011
ISSN
2162-402X
country
UScoverage
2012-2026